|
Market Cap (4-Jul) $23,106,150 (942nd) |
Close (13-Jun) $0.009 |
Volume (13-Jun) 0 |
Shortsold (8-Jun) 1,624,075 (0.07%) (501st) |
|
52w High $0.000 |
52w Low $0.000 |
P/E - |
EPS -0.02 |
CPH released this announcement to the ASX on 19 March 2021, 9:23. The announcement is not marked as price sensitive, and is 3 page(s) in length and 348.61kb in size.
You can view all announcements from CPH and see how they appear on a price chart on the announcements page.
At the date of this announcement, CPH was 0.038% short sold according to ASIC data. It was ranked the 492nd most shorted stock on the ASX. It remains ranked 501st as of the latest reported data (08 June 2023).
| Other Recent Announcements from CPH | |
|---|---|
| Notification regarding unquoted securities - CPH | 9 June 2023, 16:23 |
| LOI to Import MDMA & Psilocybin Treatments to Australia | 9 June 2023, 9:42 |
| Application for quotation of securities - CPH | 8 June 2023, 18:23 |
| New Mernova Purchase Orders & Launch of Pre-Roll Product | 19 March 2021, 9:23 |
| Final Director's Interest Notice | 17 March 2021, 18:07 |
| Halucenex Clinical Trial & Acquisition Update | 17 March 2021, 9:23 |
| Change of Director's Interest Notice | 15 March 2021, 20:11 |
You must be logged in to post a reply.
Creso Pharma 